Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for Femoral Neck Fracture Healing
jRCT2080221711Phase 3Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Neck Of Femur Fracture and osteoporosis comparing Teriparatide with Placebo (2 arms). Started Feb 2012; status: recruiting.
02
Drugs
teriparatide
03
Conditions
Neck Of Femur Fractureosteoporosis
Beyond the preview
Go deeper on jRCT2080221711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221711.